Gallberry Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-12-2024
- Paid Up Capital ₹ 4.00 M
as on 21-12-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 21-12-2024
- Revenue 68.05%
(FY 2023)
- Profit 75.38%
(FY 2023)
- Ebitda 35.07%
(FY 2023)
- Net Worth 101.90%
(FY 2023)
- Total Assets 60.00%
(FY 2023)
About Gallberry Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Gagan Deka, Benita Laishram, and Sanjay Roy serve as directors at the Company.
- CIN/LLPIN
U74999AS2018PTC018549
- Company No.
018549
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gallberry Life Sciences Private Limited offer?
Gallberry Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Dietary Supplements, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Protein Supplements, Amino Acids, Health Conditions, Liver Care.
Who are the key members and board of directors at Gallberry Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Benita Laishram  | Director | 25-Jul-2019 | Current |
| Gagan Deka | Director | 15-May-2019 | Current |
| Sanjay Roy | Director | 25-Jul-2019 | Current |
Financial Performance of Gallberry Life Sciences.
Gallberry Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.05% increase. The company also saw a substantial improvement in profitability, with a 75.38% increase in profit. The company's net worth Soared by an impressive increase of 101.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gallberry Life Sciences?
Unlock access to Gallberry Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Grossberry Lifesciences Private LimitedActive 1 year 6 monthsGagan Deka, Benita Laishram and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 26 Jul 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Gallberry Life Sciences?
Gallberry Life Sciences has a workforce of 41 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gallberry Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gallberry Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
